Stock Analysts

Starbucks Sells 46M Gift Cards in 2014 Holiday Season

Starbucks Corporation ( SBUX ) reportedly sold nearly 46 million gift cards this holiday season which we believe will boost the top line in first-quarter fiscal 2015, to be reported later this month. Per media reports, one out of every seven American received a Starbucks gift card this season, up from one in eight in 2013. Under the gift card program, Starbucks launched a uniquely designed Starbucks Card collection in November including more than 100 gift card designs. […]

Stock Analysts

Adverse Reimbursement Verdict for Cyberonics’ VNS Therapy

A medical technology company with core expertise in neuromodulation – Cyberonics Inc. ( CYBX ) – continues to run into trouble on the reimbursement front. The company recently announced that the Departmental Appeals Board (DAB) of the Department of Health and Human Services has declined its appeal on a medical reimbursement decision, taken by the Centers for Medicare & Medicaid Services (CMS) as part of the 2007 National Coverage Determination on the VNS Therapy System […]

Downgrades

FIRST BCSH/MS (FBMS) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of FIRST BCSH/MS (FBMS) from OUTPERFORM to NEUTRAL on January 06, 2015, with a target price of $16.30. The FIRST BANCSHARES, INC., headquartered in Hattiesburg, Mississippi, is the parent company of The First, A National Banking Association. The First is now ranked in the top twenty banks by asset size in Mississippi. […]

Downgrades

ATLAS PIPLN PTR (APL) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of ATLAS PIPLN PTR (APL) from OUTPERFORM to NEUTRAL on January 06, 2015, with a target price of $30.70. Atlas Pipeline Partners, L.P. and its subsidiaries engage in the transmission, gathering, and processing of natural gas in the Mid-Continent United States and the Appalachian Basin […]

Downgrades

PLURISTEM THERA (PSTI) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of PLURISTEM THERA (PSTI) from OUTPERFORM to NEUTRAL on January 06, 2015, with a target price of $3.10. PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. […]

Upgrades

HERBALIFE LTD (HLF) Upgraded by Zacks to NEUTRAL

Zacks Investment Research upgraded shares of HERBALIFE LTD (HLF) from UNDERPERFORM to NEUTRAL on January 06, 2015, with a target price of $33.90. Herbalife is a global network marketing company offering a range of science-based weight management products, nutritional supplements and personal care products intended to support weight loss and a healthy lifestyle. Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day . […]

Upgrades

GARRISON CAPITL (GARS) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of GARRISON CAPITL (GARS) from NEUTRAL to OUTPERFORM on January 06, 2015, with a target price of $15.60. Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day . To get a free copy of the research report on GARRISON CAPITL (GARS), click here […]

Stock Analysts

ON Semiconductor: A Strong Buy on Capital Allocation Plan

On Jan 6, Zacks Investment Research upgraded ON Semiconductor ( ONNN ) to a Zacks Rank #1 (Strong Buy) from a Zacks Rank #3 (Hold). The upgrade came largely on the back of the company’s enhanced capital deployment policies. The stock is currently trading at a forward P/E of 11.5x with long-term earnings growth expectation of 16.6% […]